Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 50.61%
March 31, 2026 51.98%
December 31, 2025 51.51%
September 30, 2025 53.40%
June 30, 2025 55.25%
March 31, 2025 58.80%
December 31, 2024 53.90%
September 30, 2024 56.93%
June 30, 2024 54.72%
March 31, 2024 55.45%
December 31, 2023 54.12%
September 30, 2023 54.85%
June 30, 2023 54.92%
March 31, 2023 55.81%
December 31, 2022 55.72%
September 30, 2022 55.37%
June 30, 2022 51.91%
March 31, 2022 51.73%
December 31, 2021 51.15%
September 30, 2021 51.34%
June 30, 2021 51.33%
March 31, 2021 52.54%
December 31, 2020 56.81%
September 30, 2020 53.60%
June 30, 2020 54.87%
Date Value
March 31, 2020 55.30%
December 31, 2019 62.57%
September 30, 2019 57.92%
June 30, 2019 55.46%
March 31, 2019 51.83%
December 31, 2018 58.29%
September 30, 2018 57.87%
June 30, 2018 60.34%
March 31, 2018 56.93%
December 31, 2017 48.54%
September 30, 2017 55.64%
June 30, 2017 57.16%
March 31, 2017 50.64%
December 31, 2016 52.69%
September 30, 2016 47.29%
June 30, 2016 45.66%
March 31, 2016 43.49%
December 31, 2015 35.66%
September 30, 2015 30.27%
June 30, 2015 19.83%
March 31, 2015 38.07%
December 31, 2014 30.73%
September 30, 2014 44.61%
June 30, 2014 44.16%
March 31, 2014 46.52%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
DexCom, Inc. 63.44%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 50.87%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics